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Genetic variation affecting gene regulation is a central driver of phenotypic differences between 
individuals and can be used to uncover how biological processes are organized in a cell. Although 
detecting cis-eQTLs is now routine, trans-eQTLs have proven more challenging to find due to the 
modest variance explained and the multiple tests burden of testing millions of SNPs for association to 
thousands of transcripts. Here, we successfully map trans-eQTLs with the complementary approach of 
looking for SNPs associated to the expression of multiple genes simultaneously. We find 732 trans-
eQTLs that replicate across two continental populations; each trans-eQTL controls large groups of 
target transcripts (regulons), which are part of interacting networks controlled by transcription factors. 
We are thus able to uncover co-regulated gene sets and begin describing the cell circuitry of gene 
regulation. 
 
Biological processes are carefully orchestrated events requiring precise activation and repression of 
participating genes by hierarchical gene regulation mechanisms. This elaborate co-regulation can be seen in 
the complex patterns of gene co-expression across tissues1 and conditions2; the overlap and organization of 
transcription factor target sets3; and the organization of gene interaction networks4. Furthermore, it has 
become apparent that a substantial fraction of common genetic variants driving organismal traits such as 
disease risk affect gene regulatory sequences rather than coding sequence5,6. Thus understanding how 
genetic variation influences the co-regulation of multiple genes will reveal the major regulators of biological 
processes and the molecular mechanisms underlying organismal traits, including disease susceptibility.  
 
Expression quantitative trait locus (eQTL) mapping7,8 is now routinely used to identify variants controlling gene 
expression in cis (cis-eQTLs), which are thought to perturb regulatory sequences. In contrast, variation 
affecting the regulatory machinery rather than regulatory sequences around a gene should map elsewhere in 
the genome. Whilst a handful of such trans-eQTLs have been described in humans9-12, they do not account for 
the fraction of transcript level heritability attributed to trans-acting variation13. This is likely because, unlike cis-
eQTLs where analysis can be limited to the genomic locus encoding each gene, trans-eQTL discovery requires 
genome-wide testing, and the correction required for testing millions of SNPs for association to thousands of 
transcripts renders even large studies underpowered. Thus, simple analyses which look for independent 
association evidence that many transcripts map to the same region will fail, and new approaches are required 
to sensitively detect trans-eQTLs and describe patterns of gene co-regulation. 
 
Here, we hypothesize that if variation in trans acts on the transcriptional regulation machinery, it should affect 
multiple transcripts simultaneously and thus allow us to detect co-regulated gene sets, or regulons. We pursue 
this idea by applying a second-level significance testing14 framework to detect trans-eQTLs affecting multiple 
transcripts15: in essence, our approach is to look for a shift in the distribution of eQTL association statistics at 
each SNP, indicative of association to multiple transcripts. We are thus not limited either by power to detect 
association to individual transcripts at genome-wide significance levels nor do we have to test all possible 
combinations of transcripts for association as in a standard meta-analysis16. In extant eQTL data we are able 
to identify 732 trans-eQTLs that replicate across two continental populations and that modulate the expression 
levels of multiple genes. We further show that these regulons have independent evidence of co-regulation and 
co-ordinate function on several levels. We are thus able to uncover sets of co-regulated genes in studies of 
realistic size and begin describing the large-scale organization of the transcriptome. 
 
Results 
Trans-eQTLs are common and affect hundreds of genes 
Our premise is that if a SNP affects the transcript levels of multiple genes, then there should be an excess of 
low association statistics at that SNP14. At each SNP, we test a single hypothesis: whether the association p-
values deviate from the expected distribution, which we define empirically to account for the correlation 
between gene expression levels (see Online Methods). We apply this approach to eQTL data from the CEU 
and YRI HapMap populations (109 and 108 individuals respectively17), replicating observations across the two 
datasets. We consider 8,368 transcripts detected in lymphoblasoid cell lines and 610,180 autosomal SNPs 
with minor allele frequency >15% in both populations. After data quality control and normalization, we calculate 
SNP-expression association statistics accounting for gender, and for each SNP calculate a CPMA statistic 
from the 8368 eQTL p-values. As CPMA is a distributional test and does not identify which transcripts are 
being affected, we identify trans-eQTL targets in a separate step using a two-group mixture model on the p-
value distribution. We define genes as targets if they have >80% probability of belonging to the non-null group 
(see Online Methods).  
 
We found 26792/610180 SNPs in CEU and 28013/610180 in YRI have an empirical PCPMA < 0.05, with a 
significant overlap of 1311 SNPs between these sets (hypergeometric p = 0.0079). After accounting for linkage 
disequilibrium (r2 < 0.2), we find that these represent 732 independent effects present in both populations 
(Figure 1A, B, Table S1), each affecting many genes (Figure 1C). If these effects are genuine trans-acting 
eQTLs, we expect them to fulfill two key predictions across the two populations: the genes they influence 
should be the same in the two populations; and the direction of effect of the minor allele should be consistent 
between the two populations for these genes. To account for the correlation between expression levels, we 
have developed empirical approaches to assess both these predictions (see Online Methods).  
 
For the first prediction, we assess whether the trans-eQTL has same targets across the two populations. Given 
NCEU and NYRI target genes, we observe an intersect Noverlap = NCEU {union symbol} NYRI. We construct an 
expected distribution of Noverlap across all 610,180 SNPs in the analysis and compute the empirical p-value 
Poverlap from this, which accounts for correlations between markers and between expression traits. We find that 
329/732 effects have significant overlap of target genes in the two populations  (SNP-wise Poverlap < 0.05; 
binomial probability of this number of overlaps occurring by chance p = 1.6 x 10-200), showing that we can 
replicate our trans-eQTLs across two populations. For the second, we assess whether the direction of effect is 
consistent across the two populations and find that 618/732 SNPs have SNP-wise p < 0.05 by this measure 
(binomial probability of this number of overlaps occurring by chance p < 1 x 10-300). We thus show that our 
approach detects genuine trans-eQTLs active in two continental populations and each affecting regulons 
comprised of hundreds of genes. 
 
trans-eQTLs act via cis-eQTLs 
We next hypothesized that trans-acting variants would exert their effects on their targets by perturbing genes in 
cis11. We found that they are located closer to genes than expected by chance (p = 0.016), and are more likely 
to be found within gene boundaries (p = 0.011). Overall, we found that 486/732 trans-acting variants are within 
500 kb of a gene and that we had classified a proximal gene as a regulon member for 154 of these 486, 
suggesting that a sizeable fraction of our trans-acting variants act as cis-eQTLs. We found that trans-eQTLs 
were more likely to affect the proximal gene compared to other SNPs with similar CPMA statistics  (enrichment 
of true trans-acting SNPs as cis-eQTLs p = 7.2 x 10-8 and p = 2.1 x 10-270 in CEU and YRI respectively; Figure 
2A). However, cis-eQTLs occur frequently and we wanted to establish whether our trans-acting SNPs were 
true cis-eQTLs or whether they merely reside in regions enriched for cis-eQTL activity. We therefore tested if 
they had stronger association to their cis-targets than surrounding markers and found this to be 
overwhelmingly the case (rank test p = 4.3 x 10-43 and p = 5.6 x 10-57 in CEU and YRI respectively; Figure 2B), 
showing they are likely to be the causal alleles for the observed cis-eQTL. We thus show that a substantial 
proportion of the detected trans-acting SNPs act as cis-eQTLs on proximal genes; this may be the mechanism 
by which they effect the expression of target genes encoded elsewhere in the genome.  
 
trans-eQTL targets are co-regulated  
By definition, our results imply that the genes in our 732 regulons are coordinately regulated. If so, regulon 
members should share transcriptional control machinery, so we hypothesized that we could detect co-
regulation as an enrichment of transcription factors binding to members of each regulon. We test this by 
looking for enrichment of transcription factor binding events near target genes in lymphoblasoid cell lines 
profiled by the ENCODE project. We find that 681/732 (93%) target sets are enriched for targets of at least one 
transcription factor, and 563/732 (77%) show enrichment of two or more transcription factors (Table S2). Of 
course, these results do not mean the enriched transcription factors induce the trans-eQTLs directly, but that 
the target genes are co-regulated.  
 
We further hypothesized that regulons represent functional gene modules and sought evidence of functional 
interaction between members of each set. We looked for significant protein-protein interactions between 
regulon members using DAPPLE18 and found that 101/732 (14%, binomial  p = 8.1 x 10-20) showed significant 
(p < 0.05) increase in direct connections between proteins, constituting a strong enrichment (Figure S1A). 
Furthermore, 155/732 (21%, binomial p = 1.8 x 10-52)  have evidence of participating in broader networks 
(DAPPLE’s indirect networks, Figure S1B). These results support the model that trans-eQTLs perturb 
functionally linked gene sets by altering their regulation at the transcriptional level.  
 
Next, we define a subset representing networks of interacting genes controlled by the same transcriptional 
machinery. The 36 regulons shown in Table 1 have significant target overlap, effect directionality, target protein 
connectivity and transcription factor binding in both CEU and YRI. We see a strong correlation between 
functional interaction at the protein level and transcriptional regulation among target genes: in 35/36 of these 
regulons, the genes forming direct DAPPLE protein-protein interaction networks are also enriched for targets of 
significant ENCODE transcription factors. We find that these target gene sets are in general enriched for Gene 
Ontology terms associated with cellular homeostasis, suggesting that trans-eQTLs may often affect basic cell 
processes such as mRNA and DNA homeostasis during transcription and cell division (Table S3). Thus, these 
results show that trans-acting eQTLs modulate transcriptionally coherent groups of genes involved in basic 
cellular processes. 
 
Finally, we tried to uncover what molecular changes trans-acting variants induce to influence their targets. 
Concentrating on the 36 regulons described above, we reasoned that the trans-acting variants alter the 
expression of the ENCODE transcription factors enriched for binding to each regulon. We hypothesized that 
the expression levels of each enriched factor should correlate to regulon genes. We found at least one 
significant correlation for 32/36 sets (Table 2). We found no evidence that the trans-acting variant associates 
with expression of these transcription factors directly, consistent with our above observation that these variants 
act on other genes in cis to exert their effects (Table 3). We see similar results when considering all 732 
regulons (table S2). we therefore suggest that this perturbation eventually results in alteration to transcription 
factor expression levels and hence changes target transcript expression.  
 
Discussion 
In this work we are able to identify trans-eQTLs by looking for evidence that a SNP simultaneously influences 
many transcripts. We are able to show compelling evidence for widespread trans-acting eQTLs in human cells 
replicating across continental populations, by addressing the massive multiple testing burden inherent to eQTL 
analyses. We find that large-scale co-regulation of gene sets is a common feature of the human 
transcriptome3,19, which can be uncovered by genetic analysis across populations. Some regulons vary across 
the population in concert with changes to transcription factor expression levels, although other control 
mechanisms likely exist.  
 
trans-eQTLs have proven challenging to detect in human data, despite the substantial heritability of gene 
expression attributed to them13. The modest effect sizes of trans-acting variants10,11 in part drive this failure, as 
does the systematic noise in gene expression assays20. Whilst both issues can be addressed by increasing 
sample size to boost statistical power12, the cost and logistics of ascertaining large cohorts makes this 
approach economically prohibitive, especially when considering multiple tissues21, so new analytical 
approaches are required. When considering multiple phenotypes simultaneously, as is the case with trans-
eQTLs controlling many transcripts, additional information from the expectation of shared association to boost 
power16. Our approach leverages this additional information and we are able to show – in publicly available 
data in which standard analyses have not yielded results – that trans-eQTLs are detectable in large numbers.  
 
Our results are consistent with precise regulation of biological processes, particularly basic homeostatic 
mechanisms, which may have high-level phenotypic consequences. These observations further support the 
notion that regulation of basic cell processes is highly orchestrated and occurs on several levels 
simultaneously22. Applying this approach to eQTL datasets from diverse tissues will yield rich insights into 
tissue-specific regulatory circuits driving diverse cellular processes. Finally, we note that biological exploration 
and dissection of these pathways will require new experimental tools, which can address the subtleties of 
quantitative regulatory changes in large numbers of genes.  
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Figure legends 
 
Figure 1. 732 trans-eQTLs replicate across two continental HapMap populations and affect large regulons. A: 
Empirical CPMA statistics in CEU and YRI populations. Lines indicate α < 0.05. B: Observed number of genes 
in 732 significant, independent trans-eQTL regulons. trans-acting variants target the same transcripts across 
populations (panel C: empirical P-value distribution for target overlap between the two populations for 732 
trans-eQTLs), and have the same allelic effect on their targets (panel D: empirical P-value distribution for effect 
direction consistency in the two populations). 
 
Figure 2. trans-eQTL SNPs are also cis-eQTLs. To understand how trans-acting SNPs may exert their effects 
on distal targets, we asked if they had evidence of altering the expression of genes in cis. We found that they 
had more significant cis-eQTL p-values compared to non-replicating SNPs with similar CPMA scores in each 
population (panels A and B; rank p-values compared to similar CPMA SNPs for CEU and YRI respectively). 
We also found that they were amongst the strongest cis-eQTL signals in their loci (panels C and D: rank-based 
p-values for magnitude of cis-eQTL test statistics compared to all other SNPs in the trans-acting locus).  
 
Table legends 
 
Table 1: Across-population transcriptionally coherent trans-eQTLs affect interacting gene sets bound by 
transcription factors. This narrow subset of 36 regulons satisfies all our predictions: trans-eQTL effects are 
significant in both CEU and YRI (columns 4 and 5); regulons are made up of the same genes in the two 
populations (columns 6-10) and the allelic effects are consistent in direction (column 11); and target genes 
form significant interaction networks (assessed by DAPPLE18; column 12). Each target set is also enriched for 
binding of at least one transcription factor in ENCODE chromatin immunoprecipitation data (column 13, further 
detailed in Table 2). We note that other trans-eQTLs, which do not fulfill the interaction network or transcription 
factor enrichment criteria, likely modulate their targets through other mechanisms. The explained variance in 
regulon member expression levels is shown in columns 14-17.  
 
Table 2: transcription factor expression levels correlate to regulon genes in 32/36 transcriptionally coherent 
regulons across populations. For each factor enriched for binding near regulon member genes, we correlated 
expression level in CEU and YRI to the centroid of regulon expression values (calculated as the first principal 
component; see Online Methods for details). For the majority of comparisons the correlation was significant 
(empirical P < 0.05; ns = not significant) and only 4/36 transcriptionally coherent regulons did not have at least 
one transcription factor correlated to regulon member expression. Thus, changes in expression to regulon 
members appear mediated by changes to expression of relevant transcription factors.  
 
Table 3: likely mediators of transcriptionally coherent trans-eQTLs. In 15/36 trans-eQTL loci, we found 
evidence that a gene within 500kb of the trans-acting SNP could mediate the downstream effect on regulons. 
Genes were cis-eQTLs associated to the trans-acting SNP; were part of the regulon; were significantly 
correlated to the regulon’s overall expression pattern across individuals; or were significant seeds in the 
DAPPLE18 interaction networks of the regulon members. In six instances, multiple genes are potential 
mediators of the trans-eQTL effect; this may reflect a broader disruption to the local regulatory landscape 
induced by the trans-acting SNP. 
 
Supplementary materials 
 
Figure S1: Connectivity between regulon members. Plots show histograms of DAPPLE connectivity p-values 
for (A) direct protein connectivity and (B) indirect protein connectivity for 732 significant regulons.  
 
Table S1: Significant trans-eQTLs replicating across two populations. Empirical CPMA p-values for CEU and 
YRI are listed in columns 4 and 5. Number of regulon members in CEU and YRI are listed in columns 6 and 7, 
and the observed overlap in column 8. The expected random number of overlapping regulon members 
including the 95% confidence interval are included in column 9. The p-value of trans-eQTL target overlap 
between CEU and YRI is listed in column 10. Column 11 lists the empirical p-value for allelic effect consistency 
across populations, and column 12 the p-value for protein-protein interactions (assessed by DAPPLE). Column 
13 lists the number of transcription factors whose targets are enriched among regulon members (further details 
in Table S2). 
 
Table S2: ENCODE transcription factor binding enrichment in trans-eQTL regulons. For each transcription 
factor enriched for binding near regulon member genes (number of genes in column 3, enrichment p-value in 
column 4), we correlated its expression level in CEU and YRI to the first principal component of regulon gene 
expression. The significant correlation coefficients for CEU and YRI are listed in column 5 and 6 (‘ns’: not 
significant, ‘NA’ indicates TF was not detected in the gene expression data set).  
 
Table S3: Gene ontology (GO) terms enriched in more than 20 of the 36 high confidence trans-eQTL regulons. 
We list the GO ID, GO term and number of regulons for which the term is enriched.  
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Online Methods, Brynedal et al.  
 
Data processing 
Genotype and gene expression data are described in Stranger et al. 2012 and are publicly available at Array 
Express (http://www.ebi.ac.uk/arrayexpress/) under accession numbers E-MTAB-198 and E-MTAB-264. This dataset 
comprises whole genome gene expression quantified from lymphoblastoid cell lines of individuals of the 
HapMap populations{InternationalHapMapConsortium:2005cu} (Coriell, Camden, New Jersey, United 
States). We used data from 109 Caucasians living in Utah USA, of northern and western European ancestry 
(CEU), and 108 Yoruba in Ibadan, Nigeria (YRI). Genotype data was filtered based on minor allele frequency 
of 15% in both CEU and YRI population, resulting in 610180 SNPs genome wide. Gene expression data was 
normalized using the GCMA algorithm and filtered based on inter quartile range (iqr) and mean expression 
values to exclude non-expressed genes and unvarying genes. The IQR was clearly bimodal, and a 0.25 cut 
of was used (Figure S1.A). The mean expression level of genes was also bimodal, and an intensity cut off of 
8 was employed. 
 
 
Figure SMR1. Gene expression filtering. A. inter quantile range density distribution where the vertical line indicates the 
cut of used. B. Density distribution of the full set of genes (prior to IQR filtering in black and post in blue). Vertical line 
indicates the cut off employed.  
 
CPMA calculation (MAF correction, CPMA simulation). 
In order to detect SNPs associated to the expression of multiple genes we employed a cross phenotype meta 
analysis{Cotsapas:2011hb} based on the eQTL p-values from a linear regression with sex as covariate. 
Calculated CPMA values were corrected by minor allele frequency of the analyzed SNP.  
The small sample size and large extent of correlation between genes causes deviance from the expected 
null-distribution of uniformity. We therefore created a simulated CPMA data set based on the observed 
covariance of Z scores between genes. First, 8368 correlated Z score vectors were created based on the 
Cholesky decomposition of the covariance matrix. These were transformed to p-values, and CPMA 
calculated.  
Observed CPMA values above 95 percentile of the simulated values were considered significant in each 
population. We thereafter focused on the set of SNPs that showed significant CPMA statistics in both the 
CEU and YRI data sets (significant overlap, hypergeometric p-value 0.0079). In order to focus on 
independent effects we grouped variants based on linkage disequilibrium (r2 < 0.2) and CPMA p-value using 
the clumping procedure in plink{PURCELL:2007dg}. This resulted in 732 independent trans-eQTLs and a 
background set of 83,843 SNPs. 
 
Defining regulon members and significance testing across populations 
Our CPMA statistic identifies SNPs associated to many transcripts, but not the transcripts themselves. To 
identify regulon members, for each trans-acting SNP we model the p-value distribution as a mixture of two 
Gaussian distributions with unequal mode and variance using the mclust package in R{Team:2005wf}. We 
then classified genes as belonging to one of these two distributions, requiring >80% probability to be included 
in the distribution with low mean p-values, and defined genes in this group as trans-acting SNP targets. We 
then defined a trans-eQTL regulon as the transcripts thus classified in both CEU and YRI (the intersect set).  
 
We expect true trans-eQTLs to affect the same genes across populations. To test the significance of 
observed overlaps between populations, however, we must account for the fact that transcript expression 
levels are correlated across individuals, which violates the assumptions of most overlap tests. We therefore 
assessed the overlap in gene targets of each trans-eQTL empirically while taking the observed correlation 
into account. Given NCEU and NYRI target genes, we recorded the overlap of genes between the top NCEU and 
NYRI genes at each SNP across the genome, and the significance of the observed overlap was assessed 
given this null distribution. A histogram of empirical p-values is shown in Figure 1C, in total 329 of the 732 
regulons had a p-value < 0.05. This null distribution of overlaps was used to estimate the expected random 
regulon size as included in Table 1 and S1, column 9. We also estimate the proportion of variance explained 
as the adjusted R2 from the linear regression models. 
 
Due to the correlation between expression levels, we also empirically test our prediction of allelic effect 
direction being the same across populations. For each regulon, we calculate the proportion of same-direction 
effects (using the sign of the linear regression coefficient in our eQTL calculation). We compare this to a null 
expectation calculated as the proportion of same-direction effects for the same genes at each SNP in the 
genome.  
 
We tested enrichment of Gene Ontology (GO) categories using conditional hypergeometrical tests as 
implemented in the R package GOstats [[S Falcon and R Gentleman. Using GOstats to test gene lists for GO 
term association. Bioinformatics, 23(2):257-8, 2007.]] We focused this analysis on the genes whose proteins 
were significantly interacting according to the dapple analysis (p-value < 0.05) in order to detect the 
functionality of the core regulon genes. 
 
Detecting protein-protein interactions between regulon members with DAPPLE 
We ran DAPPLE{Rossin:2011gq} for each target set of the significant trans-eQTLs under default settings. 
Enrichment of low p-values was calculated using CPMA and showed significance for both direct connections 
and indirect degree (p-values 4.8 x 10-21 and 3.6 x 10-70 respectively). 
 
Transcription factor (TF) target overlap 
We used publicly available ENCODE data{Gerstein:2012fq}, where each TF has been connected to target 
genes targets are defined using the probabilistic model TIP{Cheng:2011bd}. LCL data were downloaded from 
http://encodenets.gersteinlab.org/enets8.GM_proximal_filtered_network.txt.  
For each of the 732 trans-eQTL target sets, we investigated the overlap with each of the 50 ENCODE-
derived TF target sets. To estimate an empirical p-value for this overlap we created an null distribution for 
each regulon by randomly selecting genes with similar expression levels and obtaining the random overlap 
with the TF target set. The observed overlap was then compared to this distribution. We next determined 
whether enriched TFs were correlated to the expression levels of regulon members (first principal component 
of the scaled expression levels). Significant Pearson correlations are included in Table S2. Finally, we used a 
hypergeometric test to detect whether regulon members forming DAPPLE networks are targets of ENCODE 
TFs.   
 
cis-eQTL enrichment 
BEDtool [[ref]] was used to collect the closest distance between assayed SNPs and genes (GENCODE v.18) 
as well as the overlap between genes and SNPs. The distance to closest gene was not correlated to the 
minor allele frequency of the SNPs. We therefore compared the distance for the 732 trans-eQTLs to the full 
set of independent SNPs using Wilcoxon non-parametric rank tests. Number of actual overlaps with features 
was compared using binomial tests. 
We tested the enrichment of cis-eQTL effects among our trans-eQTLs in two complimentary ways.  First, we 
assessed whether trans-eQTLs were more likely to affect a nearby gene compared to other SNPs with 
similar CPMA scores.  For each trans-acting SNP, we compared eQTL p-values for genes within 500 kb; for 
each gene we compared the strength of association to 1000 randomly selected SNPs with similar CPMA 
scores to the trans-acting SNP.  
Secondly, we tested whether the trans-eQTL was the strongest cis-eQTL effect in the region. We therefore 
compared the strength of association between all SNPs within 500 Mb of the suspected cis-gene to the 
strength of association of the trans-eQTL..P-values were calculated as the rank of the trans-eQTLs p-value 
divided by the number of regional SNPs.    
 
Putative trans-eQTL mediators in cis: In order to detect additional potential cis-eQTL mechanisms underlying 
the trans-eQTLs we looked into the genes located within 500 kb of a set of 36 trans-eQTLs with significant 
across-population target overlap, significant across-population target directionality, significant TF target 
overlap, and significant dapple direct connectivity scores. We calculated the correlation between their 
expression levels and the first principal component of the expression levels (scaled) of the regulon members. 
We derived an empirical p-value for the correlation between potential ‘cis-genes’ and regulon members by 
permuting sample labels for the cis-gene and recalculating the correlation 1000 times.  
 
 
 
A B
F
re
q
u
e
n
cy
400 800 1200 1600
0
10
20
30
4
0
Regulon size
C target
overlap
Sívalues
Fr
eq
ue
nc
y
0 1
0
10
0
20
0
directionality
overlap
Sívalues
Fr
eq
ue
nc
y
0 1
0
20
0
40
0
60
0
D
0 1 2 3 4 5
0
1
2
3
4
5
ïORJ&(8&30$SYDOXH
ïO
RJ
<
5
,&
3
0
$
S
Y
DO
XH

Figure'1'
YRI p-values
Fr
eq
ue
nc
y
CEU p-values
Fr
eq
ue
nc
y
40
0
20
0
0
12
0
80
40
0
0 1 0 1
A
B
Cis-eQTL p-values compared to SNPs with similar CPMA score
Rank of cis-eQTL p-value compared to regional SNPs
CEU p-values
Fr
eq
ue
nc
y
YRI p-values
Fr
eq
ue
nc
y
10
0
50
0
10
0
50
0
0 1 0 1
Figure'2'
Fr
eq
ue
nc
y
0 1
0
20
40
60
p-values
Fr
eq
ue
nc
y
p-values 0 1
0
40
80
A B
Supplementary'Figure'1'
Effect	  consistency Target	  gene	  connectivity Number	  of	  TFs
SNP	  ID chr position CEU	  P	  value YRI	  P	  value CEU YRI Overlap Expected	  (95%	  CI) Overlap	  (p-­‐value) between	  populations	  (p)	   DAPPLE	  direct	  edges	  (p) enriched Median (5%	  -­‐	  95%) Median (5%	  -­‐	  95%)
rs4654727 1 21214735 0.016 0.030 2720 2664 1196 861	  (773	  -­‐	  977) 9.21E-­‐04 >1.0E-­‐5 0.01 3 2.78% (0.96	  -­‐	  6.74) 3.47% (1.54	  -­‐	  7.61)
rs3906402 1 60702323 0.047 0.050 2604 3096 1249 958	  (869	  -­‐	  1076) 0.002 >1.0E-­‐5 0.01 9 2.50% (1.08	  -­‐	  6.16) 2.62% (0.91	  -­‐	  6.39)
rs821418 1 153284423 0.042 0.043 2454 2600 1019 757	  (673	  -­‐	  871) 0.003 1.43E-­‐04 0.05 5 2.89% (1.31	  -­‐	  6.52) 2.64% (1.01	  -­‐	  6.46)
rs1618879 1 167497812 0.019 0.035 2606 2819 992 873	  (785	  -­‐	  990) 0.047 3.38E-­‐04 0.04 1 2.86% (0.83	  -­‐	  6.95) 2.74% (1.33	  -­‐	  6.25)
rs11804999 1 248322479 0.011 0.008 2641 2612 986 819	  (733	  -­‐	  935) 0.019 5.12E-­‐05 0.03 2 3.29% (1.56	  -­‐	  8.37) 4.13% (2.18	  -­‐	  8.86)
rs2309821 2 100900304 0.001 0.021 2603 2802 1412 866	  (779	  -­‐	  983) 4.09E-­‐05 >1.0E-­‐5 0.02 3 6.02% (3.12	  -­‐	  12.15) 3.20% (1.41	  -­‐	  6.51)
rs13427703 2 234247508 0.012 0.043 2692 2570 965 822	  (735	  -­‐	  937) 0.029 1.23E-­‐04 0.01 4 3.55% (1.42	  -­‐	  8.54) 2.99% (1.37	  -­‐	  6.71)
rs13426909 2 235512068 0.005 0.045 2807 2746 1043 916	  (827	  -­‐	  1033) 0.041 2.56E-­‐04 0.01 2 3.50% (1.38	  -­‐	  7.87) 2.67% (1.26	  -­‐	  6.04)
rs9853343 3 181504232 0.001 0.045 3017 2416 1004 866	  (779	  -­‐	  981) 0.032 1.33E-­‐04 0.01 5 4.97% (2.40	  -­‐	  10.55) 2.63% (1.37	  -­‐	  6.21)
rs12507259 4 5112978 0.045 0.005 2369 2666 958 750	  (665	  -­‐	  863) 0.008 7.16E-­‐05 0.02 6 2.77% (1.30	  -­‐	  6.08) 4.82% (2.27	  -­‐	  10.98)
rs6534412 4 124441989 0.046 0.015 2760 2905 1089 953	  (863	  -­‐	  1071) 0.036 1.33E-­‐04 0.01 1 1.96% (0.44	  -­‐	  5.12) 3.05% (1.36	  -­‐	  7.53)
rs155375 5 39312722 0.016 0.025 2593 2772 1178 854	  (766	  -­‐	  970) 0.001 >1.0E-­‐5 0.01 6 3.02% (1.17	  -­‐	  7.45) 2.97% (1.52	  -­‐	  7.47)
rs6866215 5 53906687 0.004 0.035 2667 2566 1226 813	  (726	  -­‐	  928) 2.25E-­‐04 >1.0E-­‐5 0.01 7 3.50% (1.41	  -­‐	  8.09) 3.19% (1.57	  -­‐	  7.15)
rs7736745 5 117089085 0.040 0.039 2657 2872 1029 907	  (818	  -­‐	  1024) 0.045 1.02E-­‐05 0.01 2 2.61% (1.11	  -­‐	  6.09) 2.75% (1.21	  -­‐	  6.49)
rs9275596 6 32681631 0.025 0.021 2785 2707 1059 896	  (807	  -­‐	  1013) 0.021 4.09E-­‐05 0.01 2 2.82% (1.16	  -­‐	  6.37) 3.22% (1.65	  -­‐	  6.89)
rs2268730 6 52402823 0.029 0.036 2494 2605 905 771	  (686	  -­‐	  886) 0.034 1.43E-­‐04 0.04 3 2.83% (0.94	  -­‐	  7.99) 3.03% (1.14	  -­‐	  7.68)
rs1936017 6 72624622 0.021 0.045 2434 2897 971 837	  (751	  -­‐	  953) 0.035 2.25E-­‐04 0.01 1 3.22% (1.59	  -­‐	  6.99) 2.23% (0.77	  -­‐	  5.61)
rs13219185 6 82079170 0.041 0.003 2437 2947 1043 853	  (766	  -­‐	  969) 0.013 >1.0E-­‐5 0.01 2 2.40% (0.51	  -­‐	  7.13) 4.31% (1.97	  -­‐	  8.77)
rs6960872 7 144702641 0.016 0.026 2580 2820 1137 864	  (777	  -­‐	  981) 0.003 3.07E-­‐05 0.04 6 3.41% (1.54	  -­‐	  8.20) 3.08% (1.33	  -­‐	  7.05)
rs10810330 9 1512369 0.049 0.025 2381 2212 743 625	  (54	  -­‐	  732) 0.040 >1.0E-­‐5 0.01 4 2.82% (1.12	  -­‐	  9.08) 4.07% (2.04	  -­‐	  9.68)
rs2200032 9 32005136 0.026 0.043 2917 2855 1414 990	  (900	  -­‐	  1109) 2.56E-­‐04 >1.0E-­‐5 0.01 2 2.54% (0.81	  -­‐	  7.13) 2.99% (1.17	  -­‐	  6.71)
rs7049166 9 112381955 0.004 0.020 2780 2956 1321 977	  (887	  -­‐	  1095) 9.62E-­‐04 >1.0E-­‐5 0.03 6 4.11% (1.86	  -­‐	  8.79) 3.03% (1.36	  -­‐	  6.83)
rs2418763 10 107301067 0.001 0.038 2878 2951 1441 1010	  (919	  -­‐	  1129) 2.46E-­‐04 >1.0E-­‐5 0.01 3 5.00% (2.41	  -­‐	  9.89) 2.71% (1.18	  -­‐	  5.88)
rs999136 10 121829203 0.021 0.032 2357 2685 952 751	  (666	  -­‐	  864) 0.009 >1.0E-­‐5 0.01 1 3.39% (1.59	  -­‐	  8.61) 2.97% (1.40	  -­‐	  7.22)
rs10766619 11 20058525 0.028 0.048 2655 2844 1100 897	  (809	  -­‐	  1015) 0.011 >1.0E-­‐5 0.02 5 2.97% (1.27	  -­‐	  7.16) 2.36% (0.92	  -­‐	  6.14)
rs2900511 12 23011944 0.007 0.031 2606 2820 1060 873	  (785	  -­‐	  990) 0.014 5.12E-­‐05 0.02 11 3.59% (1.69	  -­‐	  8.30) 3.02% (1.31	  -­‐	  6.46)
rs10878883 12 69375536 9.67E-­‐05 0.007 2566 2932 1394 894	  (806	  -­‐	  1011) 8.19E-­‐05 >1.0E-­‐5 0.02 6 7.44% (3.98	  -­‐	  14.08) 4.16% (2.04	  -­‐	  8.40)
rs10846902 12 125981163 0.006 0.020 2571 2932 1098 896	  (807	  -­‐	  1013) 0.011 1.54E-­‐04 0.02 6 4.22% (2.08	  -­‐	  9.26) 3.28% (1.40	  -­‐	  7.87)
rs7323636 13 104973086 0.036 0.015 2617 2883 1063 896	  (808	  -­‐	  1014) 0.020 1.23E-­‐04 0.01 2 2.86% (0.89	  -­‐	  6.48) 2.48% (0.69	  -­‐	  5.82)
rs4356419 15 50320288 0.050 0.013 2634 2865 1117 897	  (808	  -­‐	  1014) 0.008 8.19E-­‐05 0.05 4 2.51% (1.08	  -­‐	  5.88) 3.52% (1.76	  -­‐	  7.25)
rs961229 15 96725043 0.015 0.003 2394 3170 1231 902	  (814	  -­‐	  1018) 0.001 1.02E-­‐05 0.02 1 3.69% (1.56	  -­‐	  9.90) 4.44% (2.15	  -­‐	  9.04)
rs4572372 15 100745994 0.044 0.031 2515 2794 1069 835	  (748	  -­‐	  950) 0.006 >1.0E-­‐5 0.03 2 2.63% (1.20	  -­‐	  6.22) 2.71% (1.28	  -­‐	  7.19)
rs9912204 17 6166020 0.025 0.016 2267 2756 1029 741	  (657	  -­‐	  854) 0.002 >1.0E-­‐5 0.03 5 3.76% (1.68	  -­‐	  8.98) 3.42% (1.57	  -­‐	  8.54)
rs2154611 22 24989920 0.035 0.021 2503 2776 949 825	  (738	  -­‐	  941) 0.042 4.27E-­‐03 0.01 2 2.88% (1.16	  -­‐	  7.38) 2.88% (1.39	  -­‐	  6.91)
rs11089447 22 30794719 0.038 0.005 2554 2737 1034 830	  (743	  -­‐	  946) 0.010 5.12E-­‐05 0.02 4 2.71% (1.06	  -­‐	  6.82) 4.47% (2.33	  -­‐	  9.32)
rs5980159 X 15489506 0.004 0.036 2327 2774 967 766	  (681	  -­‐	  879) 0.009 1.02E-­‐04 0.04 5 3.96% (1.47	  -­‐	  8.07) 3.51% (1.11	  -­‐	  7.85)
trans	  eQTL	  evidence	  (CPMA) Regulon	  compositionVariant CEU	  variance	  explained	   YRI	  variance	  explained
trans-­‐acting Targets	  in
SNP regulon TF p	  value CEU YRI
rs2900511 1060 SIX5 0.009 0.52 0.60
ZNF143 0 0.28 ns
ELF1 0.044 0.65 0.80
EBF1 0.025 0.41 0.67
MEF2A 0.033 0.58 0.32
RAD21 0.034 ns ns
GABPA 0.024 -­‐0.29 -­‐0.73
BCL11A 0.032 ns 0.27
ATF3 0.03 0.60 0.76
NFKB1 0.003 0.71 0.69
rs2418763 1441 SP1 0.004 ns 0.37
NFKB1 0.006 0.67 0.66
rs10766619 1100 CTCF 0.029 0.35 ns
GABPA 0.021 -­‐0.25 -­‐0.65
NFKB1 0.025 0.69 0.68
NR2C2 0.019 ns -­‐0.21
rs10846902 1098 SP1 0.008 0.21 0.44
SIX5 0.025 0.47 0.57
ZNF143 0.006 0.26 ns
GABPA 0.002 -­‐0.29 -­‐0.68
rs10878883 1394 ZNF143 0.033 0.27 ns
EBF1 0.048 0.39 0.65
GABPA 0.02 -­‐0.28 -­‐0.71
YY1 0.007 0.58 0.44
SRF 0.044 0.63 -­‐0.29
NR2C2 0.047 ns -­‐0.23
rs10810330 743 CTCF 0.038 0.59 ns
SIX5 0.027 0.45 ns
ZNF143 0.011 0.34 0.36
USF1 0.042 ns -­‐0.37
rs6960872 1137 SP1 0.018 ns 0.32
BCL3 0.027 0.53 0.63
BCLAF1 0.029 ns -­‐0.49
POU2F2 0.044 0.73 0.88
rs2200032 1414 YY1 0.032 0.51 0.42
rs7049166 1321 CTCF 0.026 0.24 -­‐0.21
SP1 0.015 0.21 0.40
GABPA 0 -­‐0.36 -­‐0.71
USF1 0.024 -­‐0.36 -­‐0.38
USF2 0.047 0.74 0.74
rs5980159 967 SP1 0.012 ns 0.35
POU2F2 0.027 0.81 0.91
USF1 0.045 -­‐0.28 -­‐0.31
rs11089447 1034 SP1 0.002 0.21 0.38
GABPA 0.026 -­‐0.27 -­‐0.70
YY1 0.019 0.57 0.40
rs2154611 949 MAX 0.008 ns -­‐0.32
rs4356419 1117 SP1 0.041 ns 0.38
GABPA 0.003 -­‐0.34 -­‐0.74
rs7323636 1063 SP1 0.028 ns 0.37
rs9912204 1029 SIX5 0.036 0.53 0.46
MAX 0.004 ns -­‐0.23
FAM48A 0.021 -­‐0.31 ns
NR2C2 0 -­‐0.30 -­‐0.30
ZZZ3 0.041 ns ns
rs961229 1231 GABPA 0.024 -­‐0.48 -­‐0.75
rs13426909 1043 GABPA 0.007 -­‐0.34 -­‐0.73
YY1 0.026 0.56 0.42
rs13427703 965 BRCA1 0.016 -­‐0.39 -­‐0.29
rs12507259 958 SP1 0.016 ns 0.33
EP300 0.03 0.75 0.28
YY1 0.036 0.56 0.31
TCF12 0.036 -­‐0.41 ns
IRF4 0.024 -­‐0.26 ns
rs9853343 1004 SP1 0.005 0.25 0.44
ELF1 0.03 0.67 0.82
GABPA 0.001 -­‐0.26 -­‐0.68
USF1 0.044 -­‐0.30 -­‐0.39
rs1618879 992 BCL3 0.012 0.47 0.51
rs821418 1019 SP1 0.039 ns 0.36
GABPA 0.005 -­‐0.21 -­‐0.67
BCL3 0.029 0.54 0.62
rs4654727 1196 SP1 0.016 ns 0.34
rs3906402 1249 SP1 0 ns 0.39
SIX5 0.05 0.49 0.64
EP300 0.048 0.77 0.35
GABPA 0.018 -­‐0.22 -­‐0.69
BCL11A 0.042 ns 0.30
BCL3 0.042 0.52 0.62
POU2F2 0.005 0.83 0.88
rs2309821 1412 GABPA 0.037 -­‐0.45 -­‐0.76
rs11804999 986 MEF2A 0.006 0.64 0.33
rs2268730 905 USF1 0.034 -­‐0.19 -­‐0.20
IRF3 0.025 ns ns
rs9275596 1059 GABPA 0.01 -­‐0.36 -­‐0.73
BCLAF1 0.046 ns -­‐0.55
rs7736745 1029 GABPA 0.003 -­‐0.25 -­‐0.65
rs1936017 971 SRF 0.039 0.67 -­‐0.26
rs6866215 1226 SP1 0.002 ns 0.32
MEF2A 0.039 0.60 0.31
BCL3 0.036 0.49 0.59
BRCA1 0.039 -­‐0.23 ns
rs155375 1178 GABPA 0 -­‐0.34 -­‐0.74
BCL11A 0.008 ns 0.26
BCLAF1 0.047 ns -­‐0.48
TCF12 0.03 -­‐0.40 0.23
NFKB1 0.047 0.63 0.60
Regulon Transcription	  factor Correlation	  with	  regulon
	  binding	  enrichment 	  member	  expression
trans-­‐eQTL chr position Potential	  cis	  regulator Evidence
HP1BP3 part	  of	  the	  regulon
EIF4G3 cis-­‐correlation	  significant
SPRR1A cis-­‐correlation	  significant
GATAD2B cis-­‐correlation	  significant
rs11804999 1 248322480 OR2T35 cis-­‐correlation	  significant
rs13427703 2 234247509 DGKD cis-­‐correlation	  significant
rs12507259 4 5112979 MSX1 cis-­‐correlation	  significant
HLA-­‐DRB5 part	  of	  the	  regulon,	  cis-­‐eQTL	  
HLA-­‐DRB1 part	  of	  the	  regulon,	  cis-­‐eQTL
PSMB9 part	  of	  the	  regulon
MCM3 part	  of	  the	  regulon,	  cis-­‐correlation	  significant,	  significant	  DAPPLE	  seed
RN7SK cis-­‐correlation	  significant
ICK cis-­‐correlation	  significant
rs999136 10 121829204 SEC23IP part	  of	  the	  regulon,	  cis-­‐eQTL
rs10766619 11 20058526 PRMT3 part	  of	  the	  regulon
rs2900511 12 23011945 ETNK1 part	  of	  the	  regulon
rs10878883 12 69375537 NUP107 part	  of	  the	  regulon,	  cis-­‐eQTL
rs4356419 15 50320289 USP8 cis-­‐correlation	  significant
rs4572372 15 100745995 MEF2A cis-­‐correlation	  significant
MTMR3 part	  of	  the	  regulon
PES1 part	  of	  the	  regulon
SF3A1 cis-­‐correlation	  significant
DUSP18 cis-­‐correlation	  significant
SPECC1L cis-­‐correlation	  significant
ADORA2A cis-­‐correlation	  significant
UPB1 cis-­‐correlation	  significant
rs11089447 22 30794720
rs2154611 22 24989921
rs9275596 6 32681632
rs2268730 6 52402824
rs4654727 1 21214736
rs821418 1 153284424
